Are electrophysiological autonomic tests useful in the assessment of dysautonomia in Parkinson's disease?

Parkinsonism and Related Disorders

Volumn 9, Issue 3, 2003, Pages 179-183

  Zakrzewska Pniewska, Beata ^a   Jamrozik, Zygmunt ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Autonomic system; Parkinson's disease; R R interval variation; Sympathetic skin response

Indexed keywords

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DYSAUTONOMIA; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RR INTERVAL; SYMPATHETIC TONE;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC;

EID: 0037269424     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(02)00032-9     Document Type: Article

References (38)

1. Taly A.B., Muthane U.B. Involvement of peripheral nervous system in juvenile Parkinson's disease. Acta Neurol Scand. 85:1992;272-275.
2. Mano Y., Nakamuro T., Takayanagi T., Mayer R.F. Sweat function in Parkinson's disease. J Neurol. 241:1994;573-576.
3. Denišlič M., Meh D. Sympathetic skin response in Parkinsonian patients. Electromyogr Clin Neurophysiol. 36:1996;231-235.
4. Aminoff M.J., Wilcox C.S. Assessment of autonomic function in patients with a parkinsonian syndrome. Br Med J. 4:1971;80-1974.
5. Ishida G., Nakashima K., Takahashi K. Skin nerve sympathetic activity reflex latency in Parkinson's disease. Acta Neurol Scand. 81:1990;121-124.
6. Merello M., Pirtošek Z., Bishop S., Lees A.J. Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine. Clin Auton Res. 2:1992;215-219.
7. Turrka J.T., Myllylä V.V. Sweating dysfunction in Parkinson's disease. Eur Neurol. 26:1987;1-7.
8. Wang S.J., Fuh J.L., Shan D.E., Liao K.K., Lin K.P. Sympathetic skin response and R-R interval variation in Parkinson's disease. Mov Disord. 6:1993;151-157.
9. Muller T., Kuhn W., Przuntek H. Non-motor symptoms in Parkinson's disease. Significant impact on quality of life-using possible treatments. Fortsch Med. 115:(14):1997;45-48.
10. Kallio M., Haapaniemi T.H., Turkka J., et al. Heart rate variability in patients with untreated Parkinson's disease. Eur J Neurol. 7:(6):2000;667-672.
11. Haapaniemi T.H., Pursiainen V., Korpelainen J.T., Huikuri H.V., Sotaniemi K.A., Ambulatory E.C.G. and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 70:(30):2001;305-310.
12. Appenzeller O., Goos J.E. Autonomic deficit in Parkinson's syndrome. Arch Neurol. 24:1971;50-57.
13. Sandroni P., Ahlskog J.E., Fealey R.D., Low P.A. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res. 1:(2):1991;147-155.
14. Gutrecht J.A. Autonomic cardiovascular reflexes in progressive supranuclear palsy. J Auton Nerv Syst. 39:(1):1992;29-35.
15. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 155:(1):1998;60-67.
16. Kimber J., Mathias C.J., Lees A.J., et al. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain. 123:2000;1422-140.
17. Kitae S., Murata Y., Tachiki N., Okazaki M., Harada T., Nakamura S. Assessment of cardiovascular autonomic dysfunction in multiple system atrophy. Clin Auton Res. 11:2001;39-44.
18. Ozava T., Soma Y., Yoshimura N., Fukuhara N., Tanaka M., Tsuji S. Reduced morning cortisol secretion in patients with multiple system atrophy. Clin Auton Res. 11:2001;271-272.
19. Chaudhuri K.R. Autonomic dysfunction in movement disorders. Curr Opin Neurol. 14:(4):2001;505-511.
20. Holmberg B., Kallio M., Johnels B., Elam M. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes. Mov Disord. 16:(2):2001;217-225.
21. De Marinis M., Stocchi F., Gregori B., Accornero N. Sympathetic skin response and cardiovascular autonomic tests in Parkinson's disease and multiple system atrophy with autonomic failure. Mov Disord. 15:(6):2000;1215-1220.
22. Gutrecht J.A. Sympathetic skin response. J Clin Neurophysiol. 11:1994;519-524.
23. Knezevic W., Bajada S. Peripheral autonomic surface potential: a quantitative technique for recording sympathetic conduction in man. J Neurol Sci. 67:1985;239-251.
24. Zakrzewska-Pniewska B., Przybyłowski T., Byśkiniewicz K., Kostera-Pruszczyk A., Droszcz W., Emeryk-Szajewska B. Sympathetic skin response in obstructive sleep apnea syndrome. Acta Neurobiol Exp. 58:1998;113-121.
25. Haapaniemi T.H., Korpelainen J.T., Tolonen U., Suominen K., Sotaniemi K.A., Mylyla V.V. Suppressed sympathetic skin response in Parkinson disease. Clin Auton Res. 2000;33-342.
26. Low A.P., Suarez G.A., Benarroch E.E. Clinical autonomic disorders. Classification and clinical evaluation. In Low PA, editor. Clinical autonomic disorders, evaluation and management, 2nd ed. Lippincott-Raven, Philadelphia; 1997. p. 14-15.
27. Senard J.M., Brefel-Courbon C., Rascol O., Montastruc J.L. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging. 18:(7):2001;495-505.
28. Agelink M.W., Malessa R., Baumann B., et al. Standardised tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res. 11:2001;99-108.
29. Fischer M., Gemende I., Marsch W.C., Fischer P.A. Skin function and skin disorders in Parkinson's disease. J Neural Transm. 108:(2):2001;205-213.
30. Thomaides T., Bleasdale-Barr K., Ray Chandhuri K., et al. Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy, and pure autonomic failure. J Neurol. 43:1993;900-904.
31. Churchyard A., Mathias C.J., Boonkongchuen P., Lees A.J. Autonomic effects of selegiline; possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry. 63:1997;228-234.
32. Fusina S., Conte S., Bertolasi L., et al. Sympathetic skin response asymmetry in early stage idiopathic Parkinson's disease. Clin Neurophysiol. 110:(2):1999;358-366.
33. Habgarth K.E., Hallin R.G., Hongell A., Torbjork H.E., Wallin B.G. General characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand. 84:1972;164-176.
34. Mathias C.J. Cardiovascular autonomic dysfunction in parkinsonian patients. Clin Neurosci. 5:1998;153-166.
35. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res. 11:2001;351-355.
36. Matsui T.A., Nishikawa S., Saigo K., Kihara M., Takahashi M. Problems in prolonged levodopa administration of Parkinson's disease patients- from the standpoint of the autonomic nervous function. Clin Neurol. 38:(4):1998;295-300.
37. Satoh A., Serita T., Seto M., et al. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med. 40:(3):1999;371-375.
38. Haapaniemi T.H., Kallio M.A., Korpelainen J.T., et al. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. J Neurol. 247:(11):2000;868-874.